Reversible posterior leukoencephalopathy syndrome during regorafenib treatment: a case report and literature review of reversible posterior leukoencephalopathy syndrome associated with multikinase inhibitors

Clin Colorectal Cancer. 2014 Jun;13(2):127-30. doi: 10.1016/j.clcc.2013.12.003. Epub 2013 Dec 27.

¹ Division of Hematology/Oncology, Department of Medicine and the UVA Cancer Center, University of Virginia Health System, Charlottesville, VA. Electronic address: [email protected].
² Department of Pharmacy Services, University of Virginia Health System, Charlottesville, VA.
³ Division of Neuroradiology, Department of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, VA.
⁴ Department of Neurology, University of Virginia Health System, Charlottesville, VA.
⁵ Division of Hematology/Oncology, Department of Medicine and the UVA Cancer Center, University of Virginia Health System, Charlottesville, VA.

No abstract available

Keywords: Metastatic colorectal cancer; Posterior reversible encephalopathy; RPLS; Regorafenib; VEGF multikinase inhibitor; syndrome.

Publication types